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Key to whole body glucose homeostasis is the ability of fat and muscle cells to sequester the facilitative 
glucose transporter GLUT4 in an intracellular compartment from where it can be mobilized in response 
to insulin. We have previously demonstrated that this process requires ubiquitination of GLUT4 while 
numerous other studies have identified several molecules that are also required, including the insulin-
responsive aminopeptidase IRAP and its binding partner, the scaffolding protein tankyrase. In addition 
to binding IRAP, Tankyrase has also been shown to bind the deubiquinating enzyme USP25. Here we 
demonstrate that USP25 and Tankyrase interact, and colocalise with GLUT4 in insulin-sensitive cells. 
Furthermore depletion of USP25 from adipocytes reduces cellular levels of GLUT4 and concomitantly 
blunts the ability of insulin to stimulate glucose transport. Collectively, these data support our model 
that sorting of GLUT4 into its insulin-sensitive store involves a cycle of ubiquitination and subsequent 
deubiquitination.
The facilitative glucose transporter GLUT4 expressed in fat and muscle is responsible for the increased rate of glu-
cose transport into these cells in response to insulin1. In the absence of insulin, GLUT4 is retained intracellularly 
through active sequestration away from the general endosomal system into specialised GLUT4 storage vesicles 
(GSVs). It is from GSVs that GLUT4 translocates to the cell surface upon insulin binding its receptor. Following 
attenuation of the insulin signal, GLUT4 is again sequestered internally until a further insulin signal is received. 
This regulated trafficking underpins insulin-dependent postprandial clearance of plasma glucose and is defective 
in the disease states of insulin-resistance and Type-2 diabetes2.
GLUT4 enters GSVs from the trans Golgi network (TGN) in a trafficking step requiring the GGA 
(Golgi-localised γ-ear-containing, ARF-binding) family of clathrin adaptors3,4. We have previously reported that 
ubiquitination of GLUT4 is also required for its sorting into GSVs; with a ubiquitin-resistant version of GLUT4 
failing to enter GSVs and consequently not exhibiting insulin-stimulated translocation to the cell surface5. Given 
that GGAs facilitate delivery of cargo proteins from the TGN into the endosomal system through recognition of 
attached ubiquitin moieties6,7, we proposed that ubiquitinated GLUT4 is sorted into the endosomal system by 
GGA proteins and that this is a critical step for sorting into GSVs5. A caveat with this model is that ubiquitination 
serves as a signal for lysosomal delivery of proteins via the multivesicular body (MVB) pathway7; this poses the 
question as to why ubiquitination doesn’t target GLUT4 for lysosomal and degradation.
Ubiquitination is a reversible modification, and in the same way that kinases and phosphatases allow for tran-
sient phosphorylation of proteins, opposing action of ubiquitin ligases and deubiquininases (DUBs) can regulate 
ubiquitination of specific substrates8. Coordinated activity of ubiquitin ligases and DUBs allows cells to fine tune 
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down regulation of certain surface receptors by targeting ubiquitinated receptors to the lysosome via the MVB 
pathway while recycling a deubiquitinated population back to the cell surface8. Despite ubiquitination being 
absolutely required for sorting of GLUT4 into GSVs in adipocytes, only ~0.1% of the transporter is ubiquitinated 
at steady state5; an observation consistent with ubiquitination of GLUT4 being a transient modification. In this 
study we test a new hypothesis that once ubiquitination has served to direct GLUT4 into GSVs, subsequent deu-
biquitination prevents lysosomal degradation of the transporter.
To identify a candidate DUB for this process we turned to studies addressing the role of the insulin-responsive 
aminopeptidase IRAP in GLUT4 traffic. Like GLUT4, IRAP localises to GSVs and translocates to the plasma 
membrane in response to insulin9. Depletion of IRAP using siRNA in 3T3-L1 adipocytes results in reduced 
insulin-stimulated translocation of GLUT410,11 and adipose tissue of IRAP knockout mice has less GLUT4 in the 
GSV-enriched low-density microsomal fraction than wild type control12, implicating IRAP in GLUT4 sorting. 
IRAP binds to the scaffolding protein tankyrase (TNKS)13 whose knockdown also abrogates insulin-stimulated 
GLUT4 delivery to the cell surface of adipocytes11. Binding partners of TNKS, including IRAP, contain a con-
served TNKS binding motif (RXX(P/A)DG)14. Intriguingly, this motif resides in the C-terminus of USP2514, a 
deubiquitinase that has been identified as a TNKS binding protein in HEK293 cells15. Binding of both USP25 and 
IRAP to TNKS in adipocytes could serve to recruit USP25 to GSVs. This is an attractive model given that IRAP is 
required for the formation of GSVs10. USP25, thus positioned, could then serve to deubiquitinate GLUT4, rescu-
ing the transporter from lysosomal degradation.
Here we have used insulin-sensitive 3T3-L1 adipocytes to test this hypothesis. Consistent with our model, 
we demonstrate a direct interaction between USP25 and TNKS in adipocytes, both of which cofractionate with 
a subpopulation of internal GLUT4-containing membranes. We also demonstrate that USP25 is required for 
insulin-stimulated glucose transport into 3T3-L1 adipocytes and that knockdown of USP25 results in reduced 
cellular levels of GLUT4 protein.
Results
The RXXPDG motif within USP25 is required for TNKS binding in adipocytes. Our hypothe-
sis postulates that TNKS serves to recruit USP25 to GSVs. USP25 harbours a conserved TNKS binding motif 
(RXXPDG) (Fig. 1A) and has been identified as a TNKS-interacting protein in HEK293 cells14,15. To characterize 
interaction between these two proteins in insulin-sensitive cells, we expressed and purified recombinant GST-
USP25 from bacteria, and carried out pulldown assays from adipocyte lysates. Figure 1B shows that GST-USP25 
Figure 1. Mutation of the conserved arginine in the TNKS binding motif of USP25 abrogates binding from 
adipocyte cell lysate. (A) The C-termini of known sequences for human and mouse USP25, and predicted 
sequences for rat, frog (Xenopus Laevis) and zebrafish (Danio rerio) from the UniProt database were aligned 
using Vector NTI (ThermoFisher). The conserved tankyrase binding motif is in red and bold. Figures in 
brackets correspond to the first amino acid residue shown in the sequence alignment. (B) The ability of GST-
USP25 and a derivative harbouring a mutation in the conserved TNKS binding motif (GST-USP25-R1049A) 
to bind TNKS from 3T3-L1 adipocytes was assessed by incubating 10 μg of each GST fusion immobilised on 
Sepharose beads with lysate prepared from 2, 10 cm dishes of 3T3-L1 adipocyte cell lysate (4 mg total protein in 
400 μl). Immunoblot analysis was used to detect TNKS in the pulldown (upper panel) and in 1.5% of the input 
lysate and a Coomassie stained gel of the fusion proteins used for the bindings (lower panel). Full-length blots/
gels are presented in the Supplementary Information.
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precipitated endogenous TNKS from a 3T3-L1 adipocyte lysate. Mutation of the conserved arginine in the TNKS 
binding motif of USP25 (R1049A) abrogates this binding, demonstrating that the RXXPDG motif in USP25 facil-
itates interaction of the deubiquitinase from adipocytes with TNKs (Fig. 1B).
TNKS and its binding partner USP25 are enriched on GLUT4-containing membranes but 
do not translocate to the plasma membrane in response to insulin. Sorting of GLUT4 into 
insulin-responsive GSVs requires TNKS11. TNKS is found in the perinuclear region of adipocytes where it colo-
calises with GLUT413. Iodixanol gradient centrifugation of adipocyte membranes resolves GLUT4-containing 
membranes into two distinct populations with the denser of the two containing GSVs16. Figure 2(A,B) shows that 
TNKS is highly enriched in the more dense GLUT4-containing fractions consistent with its role in sorting into 
GSVs11. USP25 is also found in these fractions supporting our hypothesis that interaction with TNKS serves to 
position this deubiquitinase to function in GLUT4 sorting (Fig. 2A,B).
Figure 2. TNKS and USP25 cofractionate with GLUT4 in low-density microsome (LDM) fractions of 
adipocytes but do not translocate to the plasma membrane in response to insulin. (A) Low density microsomes 
(LDMs) prepared from serum starved 3T3-L1 adipocytes were further fractionated in a self-forming iodixanol 
gradient. Twelve fractions, collected from the bottom of the gradient were subject to immunoblot analysis 
to determine the distribution of GLUT4, TNKS and USP25. Note that fraction 1 is not a pellet, but the most 
dense fraction of the gradient. (B) ImageJ software was used to quantify the proportion of GLUT4, TNKS 
and USP25 in the two separate pools of GLUT4 contained within LDMs, fractions 1–5 and 8–12, previously 
shown to be enriched in GSVs and endosomal recycling compartments (ERC) respectively16. Error bars 
represent ± SEM, from three separate biological replicates of the fractionation. (C) Serum starved 3T3-L1 
adipocytes were incubated with (+) or without (−) 100 nM insulin for 30 minutes before being fractionated 
into soluble (Sol) and plasma membrane (PM), LDM and high density microsome (HDM)–enriched fractions. 
Immunoblot analysis was used to detect GLUT4, TNKS and USP25 in each fraction. (D) ImageJ software was 
used to quantify the proportion of total GLUT4, TNKS and USP25 in the PM and LDM fractions shown in (C). 
Error bars represent ± SEM, from three experiments of this type. Full-length blots/gels are presented in the 
Supplementary Information.
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GSV-resident proteins such as GLUT4 and IRAP translocate to the plasma membrane in response to insulin 
from internal membranes, contained within low density microsomes (LDMs) obtained via differential centrif-
ugation of adipocytes1. In contrast to GLUT4, the amount of TNKS and USP25 did not decrease in the LDM 
nor increase in plasma membrane fractions exhibit significant increases in response to insulin-stimulation 
(Fig. 2C,D).
USP25 is required to maintain GLUT4 stability and insulin-responsiveness. Data presented in 
Fig. 1 demonstrate that USP25 from adipocytes can bind TNKS, and Fig. 2 shows that while both these proteins 
are present in GSV-enriched subcellular fractions of adipocytes neither translocate to the plasma membrane in 
response to insulin. To test the hypothesis that USP25 is positioned to rescue GLUT4 from lysosomal degradation 
we investigated the effect of USP25 depletion on GLUT4 levels. siRNA mediated knockdown of USP25 in 3T3-L1 
adipocytes resulted in a decrease in the levels of GLUT4 compared to control cells (Fig. 3). Consistent with our 
previous study11, we also found that TNKS knockdown in 3T3-L1 adipocytes did not affect GLUT4 levels (Fig. 3).
To further investigate the role of USP25 in GLUT4 sorting, we examined the consequences of USP25 deple-
tion on the ability of 3T3-L1 adipocytes to respond to insulin. Adipocytes treated with control siRNA exhib-
ited ~5-fold increase in the rate of glucose uptake in response to insulin as measured by uptake of radiolabeled 
2-deoxyglucose uptake assay (Fig. 4). Knockdown of USP25 reduced this insulin response by ~50% consistent 
with a similar decrease in levels of GLUT4 (Fig. 3).
Discussion
Our previous finding that ubiquitination of GLUT4 in 3T3-L1 adipocytes is essential for sorting of the transporter 
into insulin-responsive GSVs raised the question as to how this modification differs from ubiquitination that 
targets integral membrane proteins to the MVB pathway5,7.
Our finding that only ~0.1% of cellular GLUT4 in adipocytes is ubiquitinated at steady state led us to suggest 
that GLUT4 ubiquitination is a transient modification that is reversed once its role of directing the transporter 
into GSVs has been fulfilled5. We identified USP25 as a candidate DUB to regulate this process through its inter-
action with IRAP, via TNKS13,14. This is an attractive model given that IRAP and TNKS are required for the 
formation of GSVs and insulin-regulated trafficking of GLUT4, but GLUT4 is not required for insulin-regulated 
trafficking of IRAP10,11. Further support for this novel hypothesis comes from our work using the yeast 
Saccharomyces cervisiae as a model system to study GLUT4 trafficking5,17. While expression of human GLUT4 in 
Figure 3. siRNA mediated depletion of USP25 in adipocytes results in reduced levels of GLUT4 protein. (A) 
3T3-L1 adipocytes were treated with 50 nM siRNA against either TNKS or USP25, or a scrambled control 
siRNA (Scr) using Mirus TransIT TKO reagent on days 6 and 7 post-differentiation before being harvested 
on day 8 and subject to immunoblot analysis for the indicated proteins. (B) ImageJ software was used to 
quantify levels of GLUT4 and IRAP, normalised against GAPDH, in cells treated with siRNA against TNKS or 
USP25, expressed as a percentage of their levels in cells treated with the scrambled control siRNA. Error bars 
represent ± SEM, n = 3; asterisk denotes significance. Full-length blots/gels are presented in the Supplementary 
Information.
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yeast results in its ubiquitination as in mammalian cells, in yeast this modification results in vacuolar degradation 
of the transporter5,17. These data suggest that while some aspects of regulated trafficking through the endoso-
mal system are conserved through evolution, including ubiquitination and GGA-dependent sorting, yeast lack 
some of the molecular mechanisms that exist in insulin-responsive cells to localise GLUT4 to insulin-responsive 
GSVs5,17. One possibility is that while the molecular machinery to sort GLUT4 into the endosomal system is 
present in yeast the link with a deubiquitinating enzyme evolved later, explaining why yeast degrade GLUT4 
rather than store it intracellularly5,17. Furthermore, a constitutively ubiquitinated version of GLUT4, constructed 
by fusing ubiquitin in-frame to the C-terminus, is rapidly degraded in both yeast and insulin-sensitive cells; this 
is consistent with our model as this fusion is unlikely to be a DUB substrate and thus the protein is internalized 
into MVBs and subsequently degraded.
In this study we have tested further aspects of our model that sorting of GLUT4 into GSVs requires the DUB 
USP25 to be positioned by interaction with TNKS. We have established that USP25 from adipocytes can form 
a complex with TNKS, as predicted by yeast-2-hybrid analysis and interactions between these two proteins in 
non insulin-sensitive cells14,15. These data support our hypothesis that TNKS links the GSV component IRAP 
to the DUB USP25. Previous work has shown that depletion of either IRAP or TNKS1 from 3T3-L1 adipocytes 
blunts insulin responsive glucose uptake11. Additionally, IRAP knockout mice, despite exhibiting normal glucose 
tolerance, have a reduced insulin-responsive glucose uptake and GLUT4 protein levels in isolated tissues12. These 
findings are compatible with our model of an IRAP-TNKS1-USP25 complex regulating GLUT4 traffic.
To test the hypothesis that USP25 is positioned to rescue GLUT4 from lysosomal degradation we investigated 
the consequences on GLUT4 levels of USP25 depletion. siRNA-mediated knockdown of USP25 in 3T3-L1 adipo-
cytes resulted in a decrease in both cellular GLUT4 levels (Fig. 3) and insulin-stimulated glucose uptake (Fig. 4). 
Although USP25 knockdown may exert these effects either by increasing GLUT4 degradation or reducing de 
novo biosynthesis of GLUT4, we consider the former the most likely explanation based upon known functions of 
ubiquitination. Future experiments, including investigations of whether inhibition of lysosomal hydrolases causes 
accumulation of ubiquitinated GLUT4 in cells depleted of USP25 will address this issue, but these experiments 
are confounded by our finding that robust knockdown of USP25 requires ongoing rounds of transfection with 
siRNA; a process that requires endosomal acidification. Such future studies are likely to reveal any role a ubiquiti-
nation/deubiquitination cycle plays in regulating total cellular levels of GLUT4, a long-lived protein whose steady 
state levels are regulated through lysosomal degradation18,19. DUB activity has been shown to be required for 
recycling of several plasma membrane proteins, including the epithelial sodium channel20, the Drosophila Wnt 
co-receptor Frizzled21 and the beta-2 adrenergic receptor22. Our findings however, extend this paradigm, and are 
novel in terms of sorting of a protein from the TGN through the endosomal system.
Consistent with previous studies11,23, we found that TNKS knockdown in 3T3-L1 adipocytes did not reduce 
total GLUT4 levels in adipocytes, which might have been anticipated if this protein is required to position USP25 
to deubiquitinate GLUT4 to rescue it from lysosomal degradation. TNKS knockdown in these cells does, however, 
Figure 4. siRNA mediated depletion of USP25 from adipocytes decreases insulin-stimulated glucose uptake. 
3T3-L1 adipocytes were treated with 50 nM of one of two siRNAs against USP25 (-a and -b; N.B. USP25-a 
is the siRNA shown in Fig. 3A), or a scrambled control siRNA (Scr) using Mirus TransIT TKO reagent on 
days 6 and 7 post-differentiation before being analysed on day 8. (A) Immunoblot analysis was performed to 
confirm knockdown of USP25 using GADPH as a loading control. (B) The ability of insulin (100 nM, 30 min) 
to stimulate [3H]-2-deoxyglucose uptake into these cells was assayed (each point is the mean of triplicate 
determinations, ±SEM, expressed as fold increase over basal transport rate). Full-length blots/gels are presented 
in the Supplementary Information.
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result in attenuated insulin-stimulated delivery of GLUT4 to the plasma membrane and glucose transport, as well 
as altered GLUT4 localisation within the endosomal system under basal conditions11,23, and TNKS knockout mice 
show an expanded pool of cellular GLUT424. Effects of TNKS knockdown in 3T3-L1 adipocytes are reproduced 
using pharmacological inhibition of TNKS which concomitantly alters association of TNKS with axin and the 
motor protein KIF3A11,23. These data raise the possibility that TNKS has a dual role in GLUT4 trafficking; utilizing 
both its scaffolding and enzymatic properties. One possibility is that the levels of TNKS knockdown achieved is 
adipocytes is not sufficient to mislocalise all USP25, and that remaining is sufficient to deubiquitinate GLUT4 and 
rescue it from lysosomal degradation. It is important to note that in L6 myotubes, TNKS knockdown, or treat-
ment of the cells with pharmacological inhibitors of TNKS activity, not only impairs insulin-stimulated glucose 
uptake but also reduces cellular levels of several GSV proteins including GLUT425, perhaps indicating different 
physiological roles of fat and muscle.
Intriguingly, TNKS PARsylation is known to direct ubiquitination of protein substrates including axin via the 
E3 ligase RNF14626. This finding can be used to extend our model so that IRAP recruitment of TNKS facilitates 
TNKS PARsylation of GSV components, including GLUT4, tagging them for ubiquitination to facilitate sorting 
into GSVs. USP25, recruited through interaction with TNKS, could then deubiquitinate GLUT4, trapping it in 
GSVs and preventing its trafficking to the lysosome.
Precisely where in the endosomal system such a cycle of ubiquitination/deubiquitination of GLUT4 occurs 
requires, and warrants, further investigation. GGA proteins are most associated with sorting of proteins from the 
TGN into the endosomal system through recognition of attached ubiquitin moieties6,7, suggesting that GLUT4 
may become ubiquitinated as it travels through the TGN. GLUT4 becomes trapped in a ubiquitin-enriched late 
endosomal compartment upon overexpression of dominant-negative ESCRT mutants and is unable to respond 
to insulin27; suggesting that the ubiquitinated form of the transporter transits through the late endosomal com-
partment where the ubiquitin-dependent ESCRT sorting machinery functions prior to entering GSVs. These two 
observations are consistent with our model as the compartments that make up the endosomal system are highly 
dynamic in nature. Consistent with our finding that, unlike GSV-resident proteins, USP25 and TNKS do not 
translocate to the plasma membrane in response to insulin, neither USP25 nor TNKS were identified in a com-
prehensive proteomic analysis of GSVs28, suggesting that these proteins function before GLUT4 enters its final 
storage depot in insulin-sensitive cells.
Methods
Cell culture. 3T3-L1 fibroblasts (American Tissue Culture Collection) were grown and differentiated into adi-
pocytes as described29. Prior to experimental analyses, cells were incubated in serum-free media for 2 hours and 
incubated with or without insulin as detailed in figure legends. 2-deoxy-D-glucose (deGlc) transport was assessed 
as previously described30. 3T3-L1 adipocytes were treated with 50 nM siRNA against either TNKS or USP25, or 
a scrambled control siRNA (Scr) using Mirus TransIT TKO reagent on days 6 and 7 post-differentiation before 
being harvested on day 8 and subject to immunoblot analysis for the indicated proteins.
GST-fusion pull-downs. GST-USP2531 and a version with Arg104 mutated to Ala were purified from bacteria 
and used to pull down proteins from an adipocyte lysate as described5.
Subcellular fractionation. Fractionation of adipocytes into plasma membrane (PM), high and low-density 
membranes (HDM and LDM respectively) and cytosolic (cyt) fractions was performed using a well-characterised 
and widely used protocol32. LDM fractions were further separated using Iodixanol gradient centrifugation as 
described16. To quantify the proportion of GLUT4 within GSV-enriched fractions, immunoblot signals from 
lanes 1–5 were quantified, combined and expressed as a fraction of the total GLUT4 signal across all fractions. 
Immunoblot analysis was performed using antibodies against GLUT4 and USP25 that have been described else-
where33,34. Polyclonal antibodies for IRAP were from Paul Pilch (Boston University School of Medicine). Other 
antibodies were purchased from Ambion (anti-GAPDH mouse monoclonal; clone 6C5) and Santa Cruz biotech-
nology (anti-TNKS rabbit polyclonal). Immunoblot signals were quantified using ImageJ (National Institutes of 
Health, Bethesda, MD) software.
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